864 related articles for article (PubMed ID: 27177442)
21. Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study.
Guo M; Diaz GM; Yu Y; Patel CA; Farrar JT; Asbell PA; Ying GS;
Ocul Surf; 2024 Apr; 32():112-119. PubMed ID: 38307463
[TBL] [Abstract][Full Text] [Related]
22. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
Versura P; Profazio V; Campos EC
Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
[TBL] [Abstract][Full Text] [Related]
23. Dry eye signs and symptoms in women with premature ovarian failure.
Smith JA; Vitale S; Reed GF; Grieshaber SA; Goodman LA; Vanderhoof VH; Calis KA; Nelson LM
Arch Ophthalmol; 2004 Feb; 122(2):151-6. PubMed ID: 14769589
[TBL] [Abstract][Full Text] [Related]
24. Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease.
Downie LE
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7260-8. PubMed ID: 26544794
[TBL] [Abstract][Full Text] [Related]
25. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease.
Kashkouli MB; Alemzadeh SA; Aghaei H; Pakdel F; Abdolalizadeh P; Ghazizadeh M; Moradpasandi F
Ocul Surf; 2018 Oct; 16(4):458-462. PubMed ID: 30297028
[TBL] [Abstract][Full Text] [Related]
26. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial.
Sosne G; Dunn SP; Kim C
Cornea; 2015 May; 34(5):491-6. PubMed ID: 25826322
[TBL] [Abstract][Full Text] [Related]
27. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis.
Schargus M; Wolf F; Tony HP; Meyer-Ter-Vehn T; Geerling G
Cornea; 2014 Dec; 33(12):1257-61. PubMed ID: 25255140
[TBL] [Abstract][Full Text] [Related]
28. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome.
Le Q; Ge L; Li M; Wu L; Xu J; Hong J; Gong L
Acta Ophthalmol; 2014 Mar; 92(2):e124-32. PubMed ID: 23901943
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting the ocular surface response to desiccating environmental stress.
Alex A; Edwards A; Hays JD; Kerkstra M; Shih A; de Paiva CS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3325-32. PubMed ID: 23572103
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
[TBL] [Abstract][Full Text] [Related]
31. Assessing the severity of keratitis sicca with videokeratoscopic indices.
de Paiva CS; Lindsey JL; Pflugfelder SC
Ophthalmology; 2003 Jun; 110(6):1102-9. PubMed ID: 12799233
[TBL] [Abstract][Full Text] [Related]
32. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
[TBL] [Abstract][Full Text] [Related]
33. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study.
Zou X; Lu L; Xu Y; Zhu J; He J; Zhang B; Zou H
BMC Ophthalmol; 2018 May; 18(1):117. PubMed ID: 29747621
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of dry eye after femtosecond laser-assisted cataract surgery.
Yu Y; Hua H; Wu M; Yu Y; Yu W; Lai K; Yao K
J Cataract Refract Surg; 2015 Dec; 41(12):2614-23. PubMed ID: 26796442
[TBL] [Abstract][Full Text] [Related]
36. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
[TBL] [Abstract][Full Text] [Related]
37. Rasch analysis of three dry eye questionnaires and correlates with objective clinical tests.
McAlinden C; Gao R; Wang Q; Zhu S; Yang J; Yu A; Bron AJ; Huang J
Ocul Surf; 2017 Apr; 15(2):202-210. PubMed ID: 28179131
[TBL] [Abstract][Full Text] [Related]
38. TFOS DEWS II Diagnostic Methodology report.
Wolffsohn JS; Arita R; Chalmers R; Djalilian A; Dogru M; Dumbleton K; Gupta PK; Karpecki P; Lazreg S; Pult H; Sullivan BD; Tomlinson A; Tong L; Villani E; Yoon KC; Jones L; Craig JP
Ocul Surf; 2017 Jul; 15(3):539-574. PubMed ID: 28736342
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis.
Gumus K; Yurci A; Mirza E; Arda H; Oner A; Topaktas D; Karakucuk S
Cornea; 2009 Oct; 28(9):997-1002. PubMed ID: 19724213
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome.
Yoon KC; Im SK; Kim HG; You IC
Cornea; 2011 Sep; 30(9):972-6. PubMed ID: 21705877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
